Please login to the form below

Not currently logged in
Email:
Password:

Firmagon

This page shows the latest Firmagon news and features for those working in and with pharma, biotech and healthcare.

NICE finally set to back wider use of Ferring's Firmagon

NICE finally set to back wider use of Ferring's Firmagon

Ferring's Firmagon (degarelix) has been recommended for use by the NHS in England by the country's cost-effectiveness watchdog NICE. ... This has been a long process but throughout … we have maintained our firm belief that Firmagon can have a

Latest news

  • NICE gives partial backing to Ferring's prostate cancer drug NICE gives partial backing to Ferring's prostate cancer drug

    said. "Patients with pre-existing CVD are most at risk and the evidence shows that Firmagon has a higher chance of reducing that.". ... Ferring estimates that Firmagon costs around £12, 300 ($20, 650) per course - including administration - which NICE

  • Close but no cigar

    Acne vulgaris. US, Europe. Degarelix. FIRMAGON (Ferring). Prostate cancer. US. Lanthanum carbonate.

More from news
Approximately 2 fully matching, plus 1 partially matching documents found.

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Frontera Group

A leading global patient-activation group - comprising of a digital insight consultancy, creative activation agency. Our foundations lie in behavioural...

Latest intelligence

Animation: Living With
The journey from the patient's perspective...
Danny Buckland July2022
Achieving communication excellence by targeting the right channel at the right time
By Danny Buckland...
6 trends shaping the future of personalized medicine
Senior Consultant Leah Carlisle explores the key trends discussed at the 16th annual Personalized Medicine Conference, providing expert analysis and key recommendations for biopharmaceutical innovators....